These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15588287)

  • 1. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage.
    Wilcock DM; Rojiani A; Rosenthal A; Subbarao S; Freeman MJ; Gordon MN; Morgan D
    J Neuroinflammation; 2004 Dec; 1(1):24. PubMed ID: 15588287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
    Wilcock DM; Alamed J; Gottschall PE; Grimm J; Rosenthal A; Pons J; Ronan V; Symmonds K; Gordon MN; Morgan D
    J Neurosci; 2006 May; 26(20):5340-6. PubMed ID: 16707786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.
    Wilcock DM; Rojiani A; Rosenthal A; Levkowitz G; Subbarao S; Alamed J; Wilson D; Wilson N; Freeman MJ; Gordon MN; Morgan D
    J Neurosci; 2004 Jul; 24(27):6144-51. PubMed ID: 15240806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
    Schroeter S; Khan K; Barbour R; Doan M; Chen M; Guido T; Gill D; Basi G; Schenk D; Seubert P; Games D
    J Neurosci; 2008 Jul; 28(27):6787-93. PubMed ID: 18596154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities.
    Zago W; Schroeter S; Guido T; Khan K; Seubert P; Yednock T; Schenk D; Gregg KM; Games D; Bard F; Kinney GG
    Alzheimers Dement; 2013 Oct; 9(5 Suppl):S105-15. PubMed ID: 23583235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice.
    Luo F; Rustay NR; Seifert T; Roesner B; Hradil V; Hillen H; Ebert U; Severin JM; Cox BF; Llano DA; Day M; Fox GB
    J Pharmacol Exp Ther; 2010 Dec; 335(3):580-8. PubMed ID: 20823195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576.
    Chauhan NB; Siegel GJ
    J Neurosci Res; 2003 Oct; 74(1):142-7. PubMed ID: 13130516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice.
    Morgan D
    Neurochem Int; 2006 Jul; 49(2):190-4. PubMed ID: 16740342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
    Jensen MT; Mottin MD; Cracchiolo JR; Leighty RE; Arendash GW
    Neuroscience; 2005; 130(3):667-84. PubMed ID: 15590151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice.
    Chauhan NB; Siegel GJ; Lichtor T
    J Neurosci Res; 2004 Dec; 78(5):732-41. PubMed ID: 15478192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.
    Asuni AA; Boutajangout A; Scholtzova H; Knudsen E; Li YS; Quartermain D; Frangione B; Wisniewski T; Sigurdsson EM
    Eur J Neurosci; 2006 Nov; 24(9):2530-42. PubMed ID: 17100841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage.
    Nikolic WV; Bai Y; Obregon D; Hou H; Mori T; Zeng J; Ehrhart J; Shytle RD; Giunta B; Morgan D; Town T; Tan J
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2507-12. PubMed ID: 17264212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
    Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.
    Arendash GW; Gordon MN; Diamond DM; Austin LA; Hatcher JM; Jantzen P; DiCarlo G; Wilcock D; Morgan D
    DNA Cell Biol; 2001 Nov; 20(11):737-44. PubMed ID: 11788052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vessel ultrastructure in APP23 transgenic mice after passive anti-Abeta immunotherapy and subsequent intracerebral hemorrhage.
    Burbach GJ; Vlachos A; Ghebremedhin E; Del Turco D; Coomaraswamy J; Staufenbiel M; Jucker M; Deller T
    Neurobiol Aging; 2007 Feb; 28(2):202-12. PubMed ID: 16427722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice.
    Kawahara K; Suenobu M; Yoshida A; Koga K; Hyodo A; Ohtsuka H; Kuniyasu A; Tamamaki N; Sugimoto Y; Nakayama H
    Neuroscience; 2012 Apr; 207():243-60. PubMed ID: 22342341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation.
    Van Vickle GD; Esh CL; Kalback WM; Patton RL; Luehrs DC; Kokjohn TA; Fifield FG; Fraser PE; Westaway D; McLaurin J; Lopez J; Brune D; Newel AJ; Poston M; Beach TG; Roher AE
    Biochemistry; 2007 Sep; 46(36):10317-27. PubMed ID: 17705508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of huannao yicong recipe extract on the learning and memory and related factors of Abeta generation in the brain of APP transgenic mice].
    Li H; Liu MF; Liu JG; Liu LT; Guan J; Cai LL; Hu J; Wei Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):90-4. PubMed ID: 23596795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.